-
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction. The drug is a selective aldosterone blocker, a new class of drug for the treatment of CHF.
-
The objective of this monograph is to provide an overview of the scope of allergic disorders, and review the current understanding of the mechanism of the allergic response. Due to the extensive nature of the topic, we will limit our discussion to systemic reactions eliciting an IgE-mediated response. Further, the intimate relationship between organs involved will be reviewed, particularly the relationship between allergic rhinitis and asthma. Part I includes the current evaluation, including historical features, exposures, physical exam findings, and ancillary diagnostic options will be reviewed.
-
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
-
-
-
This is the first study to examine whether nuclear transfer stem cells are effective in an animal model of Parkinsons disease. Nuclear transfer is a means of creating stem cells that are genetically identical to the donor.
-
West Nile virus may present as meningitis, encephalitis, meningoencephalomyelitis, and Guillain Barré syndrome. Poliomyelitis, as 2 well-documented cases demonstrate, must also be added to the list.
-
Helmstaedter and colleagues addressed the question of whether temporal lobe epilepsy may be associated with cognitive decline.
-
-
Deep brain stimulation (DBS) of the ventral intermediate nucleus of the thalamus is an effective procedure that markedly improves quality of life in patients with medication-refractory essential tremor. An initial wave of enthusiasm greeted the approval of DBS, but concerns have been raised about its long-term efficacy and the risks of hardware failure and infection. To address these questions, a consortium of neurologists set out to enroll patients in a longitudinal clinical trial with long-term follow-up.
